The Chase Group Executive Search Logo
“Committed to Excellence in Life Sciences Executive Search”

Recent News

Arcturus Therapeutics Secures Head of Drug Safety Through Continued Partnership with The Chase Group

March 3, 2021
The Chase Group’s track record for success continues with another executive placement secured for Arcturus Therapeutics. Entering a new stage in clinical development, Arcturus retained… Continue Reading →

Leadership Team Grows at Biologics Consulting Through Partnership with The Chase Group

January 29, 2021
Biologics Consulting, currently experiencing a season of growth, retained The Chase to build out their leadership team. Tasked with identifying a Regulatory Project Management Lead,… Continue Reading →

Alexza Pharmaceuticals Continues Partnership with The Chase Group to Seek Clinical Operations Leader

January 27, 2021
Alexza Pharmaceuticals, backed by their parent company, Ferrer, is working to develop products for the acute treatment of underserved medical needs in neuroscience. The company… Continue Reading →

The Chase Group Retained by Checkmate Pharmaceuticals to Identify Head of Regulatory Affairs

January 15, 2021
Checkmate Pharmaceuticals has once again partnered with The Chase Group to continue building its team of life sciences entrepreneurs who are devoted to discovering and… Continue Reading →

The Chase Group Successfully Completes Search for Vice President, Research & Development at Alexza Pharmaceuticals

Alexza Pharmaceuticals stands at the crossroads of innovation and advanced technology with a platform that has the potential to address unmet medical needs in neuroscience…. Continue Reading →

The Chase Group Successfully Places David Geller, MD as Head of Pulmonary & Rare Disease Clinical Development for Arcturus Therapeutics

January 5, 2021
The Chase Group (TCG) is pleased to announce the successful recruitment of David Geller, MD as the Vice President, Pulmonary and Rare Diseases Clinical Development… Continue Reading →

Head of Drug Safety Search Expands Partnership of Arcturus Therapeutics and The Chase Group

November 24, 2020
Arcturus Therapeutics is a growing company with a versatile portfolio and cutting-edge mRNA technology that can be adapted to multiple disease areas. New to clinical… Continue Reading →

Drug Safety Leadership Team Grows at Ionis Pharmaceuticals Through Continued Partnership with The Chase Group

November 16, 2020
Ionis Pharmaceuticals retained The Chase Group to identify and secure the next member of their drug safety leadership team to support a robust and continually… Continue Reading →

The Chase Group Continues Successful Collaboration with Genmab Through Placement of Vice President, CDTL

The Chase Group, known for its thorough search capabilities and expertise in Life Sciences Executive Search, was retained by Genmab Pharmaceuticals to execute a critical… Continue Reading →

The Chase Group Retained to Identify Pulmonary and Rare Disease Clinical Development Leader for Arcturus Therapeutics

The combination of expertise and passion to build transformative, life-changing medicines for patients and their families positions Arcturus Therapeutics to catalyze the next generation of… Continue Reading →
© Copyright 1993-2022 The Chase Group; All Rights Reserved.